These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22353804)

  • 41. Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers.
    Sinicrope FA; Rego RL; Foster N; Sargent DJ; Windschitl HE; Burgart LJ; Witzig TE; Thibodeau SN
    Am J Gastroenterol; 2006 Dec; 101(12):2818-25. PubMed ID: 17026563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chromosomal instability in microsatellite-unstable and stable colon cancer.
    Trautmann K; Terdiman JP; French AJ; Roydasgupta R; Sein N; Kakar S; Fridlyand J; Snijders AM; Albertson DG; Thibodeau SN; Waldman FM
    Clin Cancer Res; 2006 Nov; 12(21):6379-85. PubMed ID: 17085649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma.
    Elsaleh H; Powell B; Soontrapornchai P; Joseph D; Goria F; Spry N; Iacopetta B
    Oncology; 2000; 58(1):52-9. PubMed ID: 10644941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of chemotherapy in primary tumor of MSI-H colon cancer aged 50 years or younger].
    Chika N; Ishibashi K; Kumamoto K; Okada N; Suzuki O; Hatano S; Amano K; Matsuzawa T; Kuwabara K; Sobajima J; Kumagai Y; Baba H; Haga N; Iwama T; Ishida H; Inokuma S; Takeuchi I
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2035-7. PubMed ID: 24394004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
    Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
    Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microsatellite instability and sensitivitiy to FOLFOX treatment in metastatic colorectal cancer.
    des Guetz G; Mariani P; Cucherousset J; Benamoun M; Lagorce C; Sastre X; Le Toumelin P; Uzzan B; Perret GY; Morere JF; Breau JL; Fagard R; Schischmanoff PO
    Anticancer Res; 2007; 27(4C):2715-9. PubMed ID: 17695437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer.
    Jorissen RN; Christie M; Mouradov D; Sakthianandeswaren A; Li S; Love C; Xu ZZ; Molloy PL; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Burgess AW; Busam D; Zhao Q; Strausberg RL; Lipton L; Desai J; Gibbs P; Sieber OM
    Br J Cancer; 2015 Sep; 113(6):979-88. PubMed ID: 26305864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients.
    Sinicrope FA; Rego RL; Halling KC; Foster N; Sargent DJ; La Plant B; French AJ; Laurie JA; Goldberg RM; Thibodeau SN; Witzig TE
    Gastroenterology; 2006 Sep; 131(3):729-37. PubMed ID: 16952542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer.
    Mohan HM; Ryan E; Balasubramanian I; Kennelly R; Geraghty R; Sclafani F; Fennelly D; McDermott R; Ryan EJ; O'Donoghue D; Hyland JM; Martin ST; O'Connell PR; Gibbons D; Winter D; Sheahan K
    Eur J Surg Oncol; 2016 Nov; 42(11):1680-1686. PubMed ID: 27370895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.
    Van Cutsem E; Labianca R; Bodoky G; Barone C; Aranda E; Nordlinger B; Topham C; Tabernero J; André T; Sobrero AF; Mini E; Greil R; Di Costanzo F; Collette L; Cisar L; Zhang X; Khayat D; Bokemeyer C; Roth AD; Cunningham D
    J Clin Oncol; 2009 Jul; 27(19):3117-25. PubMed ID: 19451425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
    Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
    Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical implications of microsatellite instability in sporadic colon cancers.
    Sinicrope FA; Sargent DJ
    Curr Opin Oncol; 2009 Jul; 21(4):369-73. PubMed ID: 19444104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thymidylate synthase expression in colon carcinomas with microsatellite instability.
    Sinicrope FA; Rego RL; Halling KC; Foster NR; Sargent DJ; La Plant B; French AJ; Allegra CJ; Laurie JA; Goldberg RM; Witzig TE; Thibodeau SN
    Clin Cancer Res; 2006 May; 12(9):2738-44. PubMed ID: 16675565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer.
    Pietrantonio F; Miceli R; Raimondi A; Kim YW; Kang WK; Langley RE; Choi YY; Kim KM; Nankivell MG; Morano F; Wotherspoon A; Valeri N; Kook MC; An JY; Grabsch HI; Fucà G; Noh SH; Sohn TS; Kim S; Di Bartolomeo M; Cunningham D; Lee J; Cheong JH; Smyth EC
    J Clin Oncol; 2019 Dec; 37(35):3392-3400. PubMed ID: 31513484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.
    Dierssen JW; de Miranda NF; Ferrone S; van Puijenbroek M; Cornelisse CJ; Fleuren GJ; van Wezel T; Morreau H
    BMC Cancer; 2007 Feb; 7():33. PubMed ID: 17316446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic and predictive relevance of microsatellite instability in colorectal cancer.
    Storojeva I; Boulay JL; Heinimann K; Ballabeni P; Terracciano L; Laffer U; Mild G; Herrmann R; Rochlitz C
    Oncol Rep; 2005 Jul; 14(1):241-9. PubMed ID: 15944796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.
    Cohen SA; Wu C; Yu M; Gourgioti G; Wirtz R; Raptou G; Gkakou C; Kotoula V; Pentheroudakis G; Papaxoinis G; Karavasilis V; Pectasides D; Kalogeras KT; Fountzilas G; Grady WM
    Clin Colorectal Cancer; 2016 Jun; 15(2):164-9. PubMed ID: 26702772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of microsatellite instability in sporadic locally advanced rectal cancer following neoadjuvant radiotherapy.
    Du C; Zhao J; Xue W; Dou F; Gu J
    Histopathology; 2013 Apr; 62(5):723-30. PubMed ID: 23425253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of telomere function in gastric cancers with and without microsatellite instability.
    Pascua I; Fernández-Marcelo T; Sánchez-Pernaute A; de Juan C; Head J; Torres-García AJ; Iniesta P
    Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):162-9. PubMed ID: 25486025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.